Pfizer Inc. (NEO:PFE)

Nordstrom Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 192.68 billion. The enterprise value is 260.39 billion.

Market Cap	192.68B
Enterprise Value	260.39B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 13.12 and the forward PE ratio is 8.99.

PE Ratio	13.12
Forward PE	8.99
PS Ratio	2.21
PB Ratio	1.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.31, with an EV/FCF ratio of 15.33.

EV / Earnings	17.73
EV / Sales	2.96
EV / EBITDA	7.31
EV / EBIT	10.56
EV / FCF	15.33

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	1.08M
Profits Per Employee	181,280
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-320.93M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.88% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-15.88%
50-Day Moving Average	11.19
200-Day Moving Average	11.61
Relative Strength Index (RSI)	51.05
Average Volume (20 Days)	77,033

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.54

Income Statement

In the last 12 months, Pfizer had revenue of CAD 87.17 billion and earned 14.68 billion in profits. Earnings per share was 2.59.

Revenue	87.17B
Gross Profit	64.35B
Operating Income	24.22B
Pretax Income	14.38B
Net Income	14.68B
EBITDA	33.47B
EBIT	24.22B
Earnings Per Share (EPS)	2.59

Balance Sheet

The company has 18.09 billion in cash and 84.73 billion in debt, giving a net cash position of -66.64 billion.

Cash & Cash Equivalents	18.09B
Total Debt	84.73B
Net Cash	-66.64B
Net Cash Per Share	n/a
Equity (Book Value)	121.56B
Book Value Per Share	21.31
Working Capital	8.16B

Cash Flow

In the last 12 months, operating cash flow was 20.74 billion and capital expenditures -3.76 billion, giving a free cash flow of 16.99 billion.

Operating Cash Flow	20.74B
Capital Expenditures	-3.76B
Free Cash Flow	16.99B
FCF Per Share	n/a

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	89.68%
Buyback Yield	-0.92%
Shareholder Yield	n/a
Earnings Yield	7.62%
FCF Yield	8.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8